Aprogen Medicines Inc. (KRX:007460)

Aprogen Medicines Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 15, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	116,836	215,057	219,892	234,315	399,707	335,573
Market Cap Growth	-46.48%	-2.20%	-6.16%	-41.38%	19.11%	-10.30%
Enterprise Value	554,238	668,633	604,604	577,535	792,820	588,371
Last Close Price	5680.00	10455.00	11640.00	14400.00	25740.00	75825.00
PS Ratio	0.99	1.82	1.47	1.56	5.10	12.76
PB Ratio	0.25	0.47	0.50	0.56	0.87	-416.12
P/TBV Ratio	1.30	2.39	1.44	1.67	1.93	-
EV/Sales Ratio	4.70	5.67	4.03	3.84	10.12	22.38
Debt / Equity Ratio	0.41	0.41	0.26	0.30	0.20	-560.94
Net Debt / Equity Ratio	0.30	0.30	0.16	0.20	0.09	-536.27
Net Debt / EBITDA Ratio	-1.90	-1.90	-1.12	-1.27	-0.48	-6.13
Net Debt / FCF Ratio	-3.29	-3.29	-1.22	-1.00	-0.32	-3.63
Asset Turnover	0.18	0.18	0.25	0.25	0.14	0.04
Inventory Turnover	1.41	1.41	1.88	1.90	1.85	1.55
Quick Ratio	0.44	0.44	0.57	0.53	0.85	0.07
Current Ratio	0.97	0.97	1.19	1.15	2.35	0.24
Return on Equity (ROE)	-31.28%	-31.28%	-23.40%	-22.14%	-50.45%	-34.60%
Return on Assets (ROA)	-9.00%	-9.00%	-9.01%	-9.94%	-13.57%	-9.13%
Return on Invested Capital (ROIC)	-15.83%	-17.29%	-17.16%	-18.90%	-25.00%	-19.76%
Return on Capital Employed (ROCE)	-17.90%	-17.90%	-17.50%	-20.30%	-22.90%	-172.00%
Earnings Yield	-60.09%	-32.64%	-26.41%	-23.74%	-24.68%	-27.99%
FCF Yield	-35.65%	-19.37%	-26.22%	-35.71%	-33.30%	-35.50%
Buyback Yield / Dilution	-15.24%	-15.24%	-9.30%	-16.69%	-16.73%	-206.64%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.